4 Programs

  • CELMoDs for Multiple Myeloma

    Explore program
  • The Emerging Role of Cereblon E3 Ligase Modulators in Multiple Myeloma

    Explore program
  • Managing Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies — Part 1

    Explore program
  • Managing Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies — Part 2

    Explore program